$ Value
$23K
Shares
1,878
Price
$12
Filed
Nov 26
Insider
Name
Nayak Sanjay
Title
Chief Strategy Officer
CIK
0002012715
Roles
Transaction Details
Transaction Date
2025-11-24
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
277,860
Footnotes
Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.76 to $12.3412, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Filing Info
Nayak Sanjay's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-23 | OCUL | ▼ | $15K |
| 2026-02-12 | OCUL | ▼ | $94K |
| 2026-01-02 | OCUL | A | $0 |
| 2026-01-02 | OCUL | A | $0 |
| 2025-11-24 | OCUL | ▼ | $23K |
| 2025-08-25 | OCUL | ▼ | $23K |
| 2025-05-23 | OCUL | ▼ | $13K |
Other Insiders at OCUL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LINDSTROM RICHARD L MD | $461K | — | 2026-02-20 |
|
Heier Jeffrey S.
Chief Scientific Officer
|
— | $25K | 2026-02-23 |
|
Dugel Pravin
See Remarks
|
— | $1.3M | 2026-04-09 |
|
Notman Donald
Chief Operating Officer
|
— | $205K | 2026-02-12 |
|
Kaiser Peter
Chief Development Officer
|
— | $23K | 2026-02-23 |
|
Nayak Sanjay
Chief Strategy Officer
|
— | $108K | 2026-02-23 |
|
Waheed Nadia
Chief Medical Officer
|
— | $98K | 2026-02-20 |
|
Robinson David Wayne
Global CCO
|
— | — | 2026-01-21 |